

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 7.50063408 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 7.50063408 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.87305851 |
| 4 | protein retention in ER lumen (GO:0006621) | 5.28589121 |
| 5 | COPII vesicle coating (GO:0048208) | 5.11333483 |
| 6 | signal peptide processing (GO:0006465) | 4.86282943 |
| 7 | exocrine pancreas development (GO:0031017) | 4.61879750 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.51846620 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.51846620 |
| 10 | * activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.37323201 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.28085364 |
| 12 | * positive regulation of nuclease activity (GO:0032075) | 4.25159350 |
| 13 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.13262022 |
| 14 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.09351036 |
| 15 | * endoplasmic reticulum unfolded protein response (GO:0030968) | 4.03317624 |
| 16 | * regulation of nuclease activity (GO:0032069) | 3.92012916 |
| 17 | * cellular response to unfolded protein (GO:0034620) | 3.89914437 |
| 18 | sequestering of metal ion (GO:0051238) | 3.88083853 |
| 19 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.83516288 |
| 20 | intestinal cholesterol absorption (GO:0030299) | 3.80484986 |
| 21 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.77277085 |
| 22 | * ER-nucleus signaling pathway (GO:0006984) | 3.72538663 |
| 23 | * cellular response to topologically incorrect protein (GO:0035967) | 3.70012700 |
| 24 | valine metabolic process (GO:0006573) | 3.53981310 |
| 25 | protein maturation by protein folding (GO:0022417) | 3.53523747 |
| 26 | cysteine metabolic process (GO:0006534) | 3.53016445 |
| 27 | 4-hydroxyproline metabolic process (GO:0019471) | 3.51723709 |
| 28 | * response to endoplasmic reticulum stress (GO:0034976) | 3.43510748 |
| 29 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.41934684 |
| 30 | L-phenylalanine catabolic process (GO:0006559) | 3.39957902 |
| 31 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.39957902 |
| 32 | peptidyl-asparagine modification (GO:0018196) | 3.39882506 |
| 33 | vesicle coating (GO:0006901) | 3.36456268 |
| 34 | L-phenylalanine metabolic process (GO:0006558) | 3.31108110 |
| 35 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.31108110 |
| 36 | sulfur amino acid catabolic process (GO:0000098) | 3.24252292 |
| 37 | protein N-linked glycosylation (GO:0006487) | 3.15373359 |
| 38 | response to peptidoglycan (GO:0032494) | 3.12013589 |
| 39 | endocrine pancreas development (GO:0031018) | 3.10946773 |
| 40 | formation of translation preinitiation complex (GO:0001731) | 3.00011198 |
| 41 | * response to unfolded protein (GO:0006986) | 2.91862683 |
| 42 | proline biosynthetic process (GO:0006561) | 2.89455352 |
| 43 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.87044524 |
| 44 | protein carboxylation (GO:0018214) | 2.85440625 |
| 45 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.85440625 |
| 46 | intestinal absorption (GO:0050892) | 2.82142758 |
| 47 | complement activation, classical pathway (GO:0006958) | 2.81772782 |
| 48 | * response to topologically incorrect protein (GO:0035966) | 2.81641214 |
| 49 | aromatic amino acid family catabolic process (GO:0009074) | 2.79404769 |
| 50 | apoptotic cell clearance (GO:0043277) | 2.78736180 |
| 51 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.78458971 |
| 52 | alpha-linolenic acid metabolic process (GO:0036109) | 2.78381175 |
| 53 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.77639782 |
| 54 | peptidyl-arginine methylation (GO:0018216) | 2.70058034 |
| 55 | peptidyl-arginine N-methylation (GO:0035246) | 2.70058034 |
| 56 | pentose-phosphate shunt (GO:0006098) | 2.69900864 |
| 57 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.63858047 |
| 58 | ER overload response (GO:0006983) | 2.62959496 |
| 59 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.62665458 |
| 60 | immunoglobulin mediated immune response (GO:0016064) | 2.61618929 |
| 61 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.56172676 |
| 62 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.56137635 |
| 63 | homocysteine metabolic process (GO:0050667) | 2.55817201 |
| 64 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.54645106 |
| 65 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.53676844 |
| 66 | complement activation, alternative pathway (GO:0006957) | 2.52324029 |
| 67 | protein autoprocessing (GO:0016540) | 2.52016025 |
| 68 | cellular modified amino acid catabolic process (GO:0042219) | 2.51969616 |
| 69 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.51905927 |
| 70 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.51737506 |
| 71 | tricarboxylic acid metabolic process (GO:0072350) | 2.51495074 |
| 72 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.50816969 |
| 73 | complement activation (GO:0006956) | 2.50610214 |
| 74 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.49951746 |
| 75 | regulation of cholesterol homeostasis (GO:2000188) | 2.49667662 |
| 76 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.48693497 |
| 77 | definitive hemopoiesis (GO:0060216) | 2.48400456 |
| 78 | neutrophil activation involved in immune response (GO:0002283) | 2.47899023 |
| 79 | GDP-mannose metabolic process (GO:0019673) | 2.47667982 |
| 80 | axonemal dynein complex assembly (GO:0070286) | 2.47594672 |
| 81 | transcytosis (GO:0045056) | 2.47262742 |
| 82 | succinate metabolic process (GO:0006105) | 2.46052030 |
| 83 | cell redox homeostasis (GO:0045454) | 2.45363482 |
| 84 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.44340758 |
| 85 | positive regulation of granulocyte differentiation (GO:0030854) | 2.44029538 |
| 86 | NADPH regeneration (GO:0006740) | 2.43974552 |
| 87 | low-density lipoprotein particle clearance (GO:0034383) | 2.43186369 |
| 88 | maternal placenta development (GO:0001893) | 2.41825020 |
| 89 | detection of bacterium (GO:0016045) | 2.41695530 |
| 90 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.41651705 |
| 91 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.41456198 |
| 92 | peptide hormone processing (GO:0016486) | 2.41336600 |
| 93 | Golgi organization (GO:0007030) | 2.40347177 |
| 94 | tryptophan metabolic process (GO:0006568) | 2.38934330 |
| 95 | mitochondrial calcium ion transport (GO:0006851) | 2.38840302 |
| 96 | dosage compensation (GO:0007549) | 2.38823901 |
| 97 | negative regulation of fibrinolysis (GO:0051918) | 2.38591349 |
| 98 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.38064230 |
| 99 | peptide catabolic process (GO:0043171) | 2.37680212 |
| 100 | lysine metabolic process (GO:0006553) | 2.37665666 |
| 101 | lysine catabolic process (GO:0006554) | 2.37665666 |
| 102 | embryonic process involved in female pregnancy (GO:0060136) | 2.37514418 |
| 103 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.35740684 |
| 104 | detection of other organism (GO:0098543) | 2.35351367 |
| 105 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.34948207 |
| 106 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.34948207 |
| 107 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.34310229 |
| 108 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.33790508 |
| 109 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.32436296 |
| 110 | urea metabolic process (GO:0019627) | 2.31757778 |
| 111 | urea cycle (GO:0000050) | 2.31757778 |
| 112 | serine family amino acid biosynthetic process (GO:0009070) | 2.31537705 |
| 113 | regulation of protein activation cascade (GO:2000257) | 2.30345325 |
| 114 | regulation of B cell differentiation (GO:0045577) | 2.29502244 |
| 115 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.29314980 |
| 116 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.29136953 |
| 117 | glyoxylate metabolic process (GO:0046487) | 2.27882238 |
| 118 | B cell mediated immunity (GO:0019724) | 2.27253580 |
| 119 | indole-containing compound catabolic process (GO:0042436) | 2.26765934 |
| 120 | indolalkylamine catabolic process (GO:0046218) | 2.26765934 |
| 121 | tryptophan catabolic process (GO:0006569) | 2.26765934 |
| 122 | mannose metabolic process (GO:0006013) | 2.26687807 |
| 123 | positive regulation of B cell differentiation (GO:0045579) | 2.26473719 |
| 124 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.26428158 |
| 125 | respiratory burst (GO:0045730) | 2.25803698 |
| 126 | ribosome assembly (GO:0042255) | 2.25560536 |
| 127 | localization within membrane (GO:0051668) | 2.25327446 |
| 128 | plasma lipoprotein particle clearance (GO:0034381) | 2.24823751 |
| 129 | actin nucleation (GO:0045010) | 2.24730031 |
| 130 | high-density lipoprotein particle remodeling (GO:0034375) | 2.24437759 |
| 131 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.23980179 |
| 132 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.23980179 |
| 133 | amyloid precursor protein catabolic process (GO:0042987) | 2.23782453 |
| 134 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.23754545 |
| 135 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.23612058 |
| 136 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.23187520 |
| 137 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.22028260 |
| 138 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.22028260 |
| 139 | pinocytosis (GO:0006907) | 2.19154605 |
| 140 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.16249804 |
| 141 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.14208277 |
| 142 | negative regulation of interleukin-17 production (GO:0032700) | 2.13547724 |
| 143 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.07959183 |
| 144 | response to muramyl dipeptide (GO:0032495) | 2.07085475 |
| 145 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 2.05995934 |
| 146 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.04757756 |
| 147 | deoxyribose phosphate catabolic process (GO:0046386) | 2.04429840 |
| 148 | glycolipid catabolic process (GO:0019377) | 2.04233977 |
| 149 | NIK/NF-kappaB signaling (GO:0038061) | 2.04174701 |
| 150 | B cell receptor signaling pathway (GO:0050853) | 2.03682663 |
| 151 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.02108420 |
| 152 | cellular response to antibiotic (GO:0071236) | 2.00846476 |
| 153 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 1.99066520 |
| 154 | primary alcohol catabolic process (GO:0034310) | 1.99018737 |
| 155 | glycosphingolipid catabolic process (GO:0046479) | 1.96884530 |
| 156 | deoxyribonucleotide catabolic process (GO:0009264) | 1.96211845 |
| 157 | response to UV-B (GO:0010224) | 1.95329931 |
| 158 | regulation of gamma-delta T cell activation (GO:0046643) | 1.95041430 |
| 159 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 1.93700415 |
| 160 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 1.93514193 |
| 161 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 1.93199906 |
| 162 | positive regulation of interleukin-2 production (GO:0032743) | 1.92920637 |
| 163 | regulation of B cell receptor signaling pathway (GO:0050855) | 1.92483988 |
| 164 | surfactant homeostasis (GO:0043129) | 1.92458918 |
| 165 | polyamine biosynthetic process (GO:0006596) | 1.92234049 |
| 166 | regulation of interleukin-17 production (GO:0032660) | 1.92140314 |
| 167 | programmed necrotic cell death (GO:0097300) | 1.91682094 |
| 168 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 1.91305923 |
| 169 | positive regulation of mitochondrial fission (GO:0090141) | 1.90740039 |
| 170 | nitrogen cycle metabolic process (GO:0071941) | 1.90405362 |
| 171 | response to host immune response (GO:0052572) | 1.89983024 |
| 172 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 1.89983024 |
| 173 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 1.89929822 |
| 174 | regulation of defense response to virus by virus (GO:0050690) | 1.89839352 |
| 175 | nucleotide-sugar biosynthetic process (GO:0009226) | 1.89545964 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.77979697 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.52067357 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.92796481 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.50095639 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.34087271 |
| 6 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.80364757 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.78517871 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.74194514 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.50690837 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.45277540 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.41884398 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.29402262 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.25902524 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.20363008 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.16305756 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.15643117 |
| 17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.12267954 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.10447396 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.09836562 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06198030 |
| 21 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.99425256 |
| 22 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.92356781 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.91928438 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.90915074 |
| 25 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.89868109 |
| 26 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.88685379 |
| 27 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.88352348 |
| 28 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.86458226 |
| 29 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.85616037 |
| 30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84247970 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.83467662 |
| 32 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.82259698 |
| 33 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.81886915 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.79353242 |
| 35 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.76537145 |
| 36 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74861895 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.74483829 |
| 38 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.70600194 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.68740719 |
| 40 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.67248846 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.65969363 |
| 42 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.65142540 |
| 43 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.64646985 |
| 44 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.61897222 |
| 45 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.59452791 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.58301187 |
| 47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.56045758 |
| 48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.52679922 |
| 49 | MYB_26560356_Chip-Seq_TH2_Human | 1.52166096 |
| 50 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.52063675 |
| 51 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.50654075 |
| 52 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.50287634 |
| 53 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.50198850 |
| 54 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.49969830 |
| 55 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.48800242 |
| 56 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.48735249 |
| 57 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.47228580 |
| 58 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.46609414 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.45164269 |
| 60 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.44993429 |
| 61 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.43518929 |
| 62 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.42509004 |
| 63 | MYB_26560356_Chip-Seq_TH1_Human | 1.42296120 |
| 64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41730711 |
| 65 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.40891759 |
| 66 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.39908137 |
| 67 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.39051147 |
| 68 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.38427535 |
| 69 | MAF_26560356_Chip-Seq_TH1_Human | 1.35681576 |
| 70 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35588885 |
| 71 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35280112 |
| 72 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.35169089 |
| 73 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.34386794 |
| 74 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.33907544 |
| 75 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.33704121 |
| 76 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.33443020 |
| 77 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.32017090 |
| 78 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.31369620 |
| 79 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30156823 |
| 80 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27338110 |
| 81 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.24969971 |
| 82 | UTX_26944678_Chip-Seq_JUKART_Human | 1.24492233 |
| 83 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.24411783 |
| 84 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.24224342 |
| 85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23002245 |
| 86 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.21181283 |
| 87 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20054194 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19714674 |
| 89 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.19587152 |
| 90 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.19427171 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18108609 |
| 92 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.17765190 |
| 93 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.17640939 |
| 94 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.16910952 |
| 95 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.16178370 |
| 96 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.14921431 |
| 97 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.14919332 |
| 98 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14121037 |
| 99 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.13764624 |
| 100 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.13306409 |
| 101 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.12678726 |
| 102 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10852011 |
| 103 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09212590 |
| 104 | * ELF5_23300383_ChIP-Seq_T47D_Human | 1.07832885 |
| 105 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07770392 |
| 106 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07131248 |
| 107 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07067932 |
| 108 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07054966 |
| 109 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06965900 |
| 110 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.05951771 |
| 111 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04986559 |
| 112 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.03716601 |
| 113 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.03086019 |
| 114 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02704113 |
| 115 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.02399062 |
| 116 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01965737 |
| 117 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01487768 |
| 118 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.01450110 |
| 119 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.00109835 |
| 120 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.99319738 |
| 121 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.99149926 |
| 122 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98699226 |
| 123 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.98573854 |
| 124 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97942225 |
| 125 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.95490282 |
| 126 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94929157 |
| 127 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94453038 |
| 128 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.94089740 |
| 129 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.93950908 |
| 130 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.92289044 |
| 131 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92090911 |
| 132 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.90934610 |
| 133 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90777632 |
| 134 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90713545 |
| 135 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.89882577 |
| 136 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88448233 |
| 137 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86658233 |
| 138 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.84272330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.80252263 |
| 2 | MP0005365_abnormal_bile_salt | 3.22722622 |
| 3 | MP0005360_urolithiasis | 2.73302724 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.70432495 |
| 5 | MP0001666_abnormal_nutrient_absorption | 2.63860901 |
| 6 | MP0005220_abnormal_exocrine_pancreas | 2.58443632 |
| 7 | MP0004782_abnormal_surfactant_physiolog | 2.53081527 |
| 8 | MP0005083_abnormal_biliary_tract | 2.47795359 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 2.41743692 |
| 10 | MP0002009_preneoplasia | 2.37917791 |
| 11 | MP0003303_peritoneal_inflammation | 2.22550822 |
| 12 | MP0003195_calcinosis | 2.20755648 |
| 13 | MP0005451_abnormal_body_composition | 2.16569420 |
| 14 | MP0003252_abnormal_bile_duct | 2.06651709 |
| 15 | MP0002877_abnormal_melanocyte_morpholog | 2.06542730 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.04252311 |
| 17 | MP0008260_abnormal_autophagy | 1.96568970 |
| 18 | MP0006054_spinal_hemorrhage | 1.92265272 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 1.90957382 |
| 20 | MP0005058_abnormal_lysosome_morphology | 1.87521703 |
| 21 | MP0002693_abnormal_pancreas_physiology | 1.86014248 |
| 22 | MP0003436_decreased_susceptibility_to | 1.85115993 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.84756536 |
| 24 | MP0004264_abnormal_extraembryonic_tissu | 1.75286076 |
| 25 | MP0001944_abnormal_pancreas_morphology | 1.75224861 |
| 26 | MP0003183_abnormal_peptide_metabolism | 1.72841623 |
| 27 | MP0009840_abnormal_foam_cell | 1.70898616 |
| 28 | MP0008875_abnormal_xenobiotic_pharmacok | 1.65166523 |
| 29 | MP0003868_abnormal_feces_composition | 1.64456171 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 1.63340147 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.63331805 |
| 32 | MP0009643_abnormal_urine_homeostasis | 1.58213848 |
| 33 | MP0001790_abnormal_immune_system | 1.56863772 |
| 34 | MP0005387_immune_system_phenotype | 1.56863772 |
| 35 | MP0003221_abnormal_cardiomyocyte_apopto | 1.55660750 |
| 36 | MP0000685_abnormal_immune_system | 1.55621559 |
| 37 | MP0002796_impaired_skin_barrier | 1.54092652 |
| 38 | MP0002166_altered_tumor_susceptibility | 1.52936248 |
| 39 | MP0003705_abnormal_hypodermis_morpholog | 1.52718807 |
| 40 | MP0009278_abnormal_bone_marrow | 1.49893096 |
| 41 | MP0001800_abnormal_humoral_immune | 1.49073089 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.48612256 |
| 43 | MP0001545_abnormal_hematopoietic_system | 1.48612256 |
| 44 | MP0000609_abnormal_liver_physiology | 1.48039403 |
| 45 | MP0010329_abnormal_lipoprotein_level | 1.46398954 |
| 46 | MP0002132_abnormal_respiratory_system | 1.44444186 |
| 47 | MP0008438_abnormal_cutaneous_collagen | 1.41203052 |
| 48 | MP0002722_abnormal_immune_system | 1.33473851 |
| 49 | MP0005501_abnormal_skin_physiology | 1.32386107 |
| 50 | MP0005000_abnormal_immune_tolerance | 1.31975416 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.31847469 |
| 52 | MP0002452_abnormal_antigen_presenting | 1.31290898 |
| 53 | MP0004957_abnormal_blastocyst_morpholog | 1.26315563 |
| 54 | MP0005332_abnormal_amino_acid | 1.26306083 |
| 55 | MP0002419_abnormal_innate_immunity | 1.26197888 |
| 56 | MP0001853_heart_inflammation | 1.26099838 |
| 57 | MP0004808_abnormal_hematopoietic_stem | 1.25054576 |
| 58 | MP0004947_skin_inflammation | 1.24967278 |
| 59 | MP0010352_gastrointestinal_tract_polyps | 1.24809173 |
| 60 | MP0002429_abnormal_blood_cell | 1.24754497 |
| 61 | MP0005025_abnormal_response_to | 1.21016803 |
| 62 | MP0001873_stomach_inflammation | 1.20811085 |
| 63 | MP0008007_abnormal_cellular_replicative | 1.20742193 |
| 64 | MP0002396_abnormal_hematopoietic_system | 1.19670813 |
| 65 | MP0002723_abnormal_immune_serum | 1.18957092 |
| 66 | MP0009785_altered_susceptibility_to | 1.18787096 |
| 67 | MP0008469_abnormal_protein_level | 1.18417145 |
| 68 | MP0010155_abnormal_intestine_physiology | 1.16235553 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.15925953 |
| 70 | MP0005319_abnormal_enzyme/_coenzyme | 1.13218999 |
| 71 | MP0002928_abnormal_bile_duct | 1.12703334 |
| 72 | MP0002118_abnormal_lipid_homeostasis | 1.09626353 |
| 73 | MP0005671_abnormal_response_to | 1.09000782 |
| 74 | MP0002420_abnormal_adaptive_immunity | 1.07956444 |
| 75 | MP0002019_abnormal_tumor_incidence | 1.07020828 |
| 76 | MP0005084_abnormal_gallbladder_morpholo | 1.06427238 |
| 77 | MP0003186_abnormal_redox_activity | 1.05944974 |
| 78 | MP0001819_abnormal_immune_cell | 1.05850406 |
| 79 | MP0001851_eye_inflammation | 1.04559883 |
| 80 | MP0005464_abnormal_platelet_physiology | 1.04447807 |
| 81 | MP0000703_abnormal_thymus_morphology | 1.03785215 |
| 82 | MP0003724_increased_susceptibility_to | 1.03346926 |
| 83 | * MP0002078_abnormal_glucose_homeostasis | 1.02076527 |
| 84 | MP0005636_abnormal_mineral_homeostasis | 1.02059245 |
| 85 | MP0000598_abnormal_liver_morphology | 1.01778642 |
| 86 | MP0000013_abnormal_adipose_tissue | 1.01148355 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 0.99664374 |
| 88 | MP0005310_abnormal_salivary_gland | 0.99305255 |
| 89 | MP0005408_hypopigmentation | 0.98614968 |
| 90 | MP0002933_joint_inflammation | 0.97870118 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.96710551 |
| 92 | MP0001727_abnormal_embryo_implantation | 0.95700286 |
| 93 | MP0005076_abnormal_cell_differentiation | 0.95421466 |
| 94 | MP0001881_abnormal_mammary_gland | 0.94639257 |
| 95 | MP0005166_decreased_susceptibility_to | 0.94225403 |
| 96 | MP0004043_abnormal_pH_regulation | 0.94102059 |
| 97 | MP0003075_altered_response_to | 0.93254626 |
| 98 | MP0008004_abnormal_stomach_pH | 0.92943549 |
| 99 | MP0001216_abnormal_epidermal_layer | 0.92305781 |
| 100 | MP0002148_abnormal_hypersensitivity_rea | 0.92275964 |
| 101 | MP0002006_tumorigenesis | 0.91324150 |
| 102 | MP0002909_abnormal_adrenal_gland | 0.90899422 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.90819199 |
| 104 | MP0001756_abnormal_urination | 0.90637246 |
| 105 | MP0003172_abnormal_lysosome_physiology | 0.90412581 |
| 106 | MP0000313_abnormal_cell_death | 0.88778539 |
| 107 | MP0005621_abnormal_cell_physiology | 0.87330859 |
| 108 | MP0000716_abnormal_immune_system | 0.87057365 |
| 109 | MP0001764_abnormal_homeostasis | 0.86650550 |
| 110 | MP0002405_respiratory_system_inflammati | 0.86562482 |
| 111 | MP0003448_altered_tumor_morphology | 0.85780719 |
| 112 | MP0003656_abnormal_erythrocyte_physiolo | 0.84842926 |
| 113 | MP0000689_abnormal_spleen_morphology | 0.84011774 |
| 114 | MP0009333_abnormal_splenocyte_physiolog | 0.83772780 |
| 115 | MP0002398_abnormal_bone_marrow | 0.83306813 |
| 116 | MP0000858_altered_metastatic_potential | 0.83298072 |
| 117 | MP0009764_decreased_sensitivity_to | 0.83246571 |
| 118 | MP0000350_abnormal_cell_proliferation | 0.82770213 |
| 119 | MP0008057_abnormal_DNA_replication | 0.82006710 |
| 120 | MP0005023_abnormal_wound_healing | 0.81986039 |
| 121 | MP0000477_abnormal_intestine_morphology | 0.81650731 |
| 122 | MP0000343_altered_response_to | 0.80816040 |
| 123 | MP0004019_abnormal_vitamin_homeostasis | 0.80566678 |
| 124 | MP0003866_abnormal_defecation | 0.80408767 |
| 125 | MP0001765_abnormal_ion_homeostasis | 0.80083994 |
| 126 | MP0006082_CNS_inflammation | 0.79693244 |
| 127 | MP0002896_abnormal_bone_mineralization | 0.79241963 |
| 128 | MP0000490_abnormal_crypts_of | 0.79184043 |
| 129 | MP0000358_abnormal_cell_content/ | 0.79172751 |
| 130 | * MP0003795_abnormal_bone_structure | 0.79103616 |
| 131 | MP0000465_gastrointestinal_hemorrhage | 0.78656830 |
| 132 | MP0001730_embryonic_growth_arrest | 0.78434348 |
| 133 | MP0009763_increased_sensitivity_to | 0.78316267 |
| 134 | MP0009931_abnormal_skin_appearance | 0.78278157 |
| 135 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77707703 |
| 136 | MP0009384_cardiac_valve_regurgitation | 0.77350440 |
| 137 | MP0003959_abnormal_lean_body | 0.76923656 |
| 138 | MP0003763_abnormal_thymus_physiology | 0.76685615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 4.12121143 |
| 2 | Abnormality of the intrinsic pathway (HP:0010989) | 4.09481396 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.85983606 |
| 4 | Abnormality of the common coagulation pathway (HP:0010990) | 3.57467916 |
| 5 | Hypoglycemic seizures (HP:0002173) | 3.55553864 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 3.54911542 |
| 7 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.43266307 |
| 8 | Chronic bronchitis (HP:0004469) | 3.40489653 |
| 9 | Dysostosis multiplex (HP:0000943) | 3.34834382 |
| 10 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.27529704 |
| 11 | Mucopolysacchariduria (HP:0008155) | 3.27529704 |
| 12 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.27055065 |
| 13 | Intrahepatic cholestasis (HP:0001406) | 3.11200172 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.07033039 |
| 15 | Xanthomatosis (HP:0000991) | 3.06638620 |
| 16 | Symptomatic seizures (HP:0011145) | 2.93986342 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.93146678 |
| 18 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.92829627 |
| 19 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.92829627 |
| 20 | Petechiae (HP:0000967) | 2.91231061 |
| 21 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.90566184 |
| 22 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.90566184 |
| 23 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.90566184 |
| 24 | Ketoacidosis (HP:0001993) | 2.84305507 |
| 25 | Absent/shortened dynein arms (HP:0200106) | 2.84293822 |
| 26 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.84293822 |
| 27 | Recurrent sinusitis (HP:0011108) | 2.83542236 |
| 28 | Deep venous thrombosis (HP:0002625) | 2.82339336 |
| 29 | Eczematoid dermatitis (HP:0000976) | 2.79991650 |
| 30 | Late onset (HP:0003584) | 2.74970687 |
| 31 | Prolonged partial thromboplastin time (HP:0003645) | 2.74158050 |
| 32 | Fat malabsorption (HP:0002630) | 2.73971212 |
| 33 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.72950089 |
| 34 | Ketosis (HP:0001946) | 2.72597998 |
| 35 | Myocardial infarction (HP:0001658) | 2.69833753 |
| 36 | Bronchiectasis (HP:0002110) | 2.68512019 |
| 37 | Rhinitis (HP:0012384) | 2.67331270 |
| 38 | Hyperactive renin-angiotensin system (HP:0000841) | 2.65904650 |
| 39 | Chronic obstructive pulmonary disease (HP:0006510) | 2.65202628 |
| 40 | Obstructive lung disease (HP:0006536) | 2.65202628 |
| 41 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.63300854 |
| 42 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.63300854 |
| 43 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.58268607 |
| 44 | Nasal polyposis (HP:0100582) | 2.54210393 |
| 45 | Complement deficiency (HP:0004431) | 2.52617021 |
| 46 | Bronchitis (HP:0012387) | 2.49227472 |
| 47 | Thoracolumbar scoliosis (HP:0002944) | 2.48160279 |
| 48 | Abnormality of macrophages (HP:0004311) | 2.46996153 |
| 49 | Cellulitis (HP:0100658) | 2.46930779 |
| 50 | Abnormal ciliary motility (HP:0012262) | 2.44938357 |
| 51 | Abnormality of the anterior horn cell (HP:0006802) | 2.43198774 |
| 52 | Degeneration of anterior horn cells (HP:0002398) | 2.43198774 |
| 53 | Generalized aminoaciduria (HP:0002909) | 2.43046876 |
| 54 | Colitis (HP:0002583) | 2.42269654 |
| 55 | Chronic diarrhea (HP:0002028) | 2.41807831 |
| 56 | Hepatosplenomegaly (HP:0001433) | 2.40618105 |
| 57 | Abnormality of purine metabolism (HP:0004352) | 2.39028632 |
| 58 | Hypobetalipoproteinemia (HP:0003563) | 2.39025444 |
| 59 | Recurrent bacterial skin infections (HP:0005406) | 2.37605699 |
| 60 | Interstitial pulmonary disease (HP:0006530) | 2.37516029 |
| 61 | Recurrent viral infections (HP:0004429) | 2.37142902 |
| 62 | Hyperglycemia (HP:0003074) | 2.36435219 |
| 63 | Conjugated hyperbilirubinemia (HP:0002908) | 2.34534006 |
| 64 | Abnormality of the nasal mucosa (HP:0000433) | 2.34266384 |
| 65 | Mediastinal lymphadenopathy (HP:0100721) | 2.30891483 |
| 66 | Recurrent bronchitis (HP:0002837) | 2.29865337 |
| 67 | Joint hemorrhage (HP:0005261) | 2.29032181 |
| 68 | Abnormality of the prostate (HP:0008775) | 2.28033675 |
| 69 | Agammaglobulinemia (HP:0004432) | 2.26545764 |
| 70 | Urticaria (HP:0001025) | 2.25709784 |
| 71 | Abnormality of T cell physiology (HP:0011840) | 2.25546038 |
| 72 | Gout (HP:0001997) | 2.24093299 |
| 73 | Thrombocytosis (HP:0001894) | 2.22970489 |
| 74 | Steatorrhea (HP:0002570) | 2.22325613 |
| 75 | Mitral stenosis (HP:0001718) | 2.20352199 |
| 76 | Purpura (HP:0000979) | 2.19706140 |
| 77 | Inflammation of the large intestine (HP:0002037) | 2.19537083 |
| 78 | Seborrheic dermatitis (HP:0001051) | 2.17699792 |
| 79 | Gastrointestinal inflammation (HP:0004386) | 2.17626132 |
| 80 | Increased IgE level (HP:0003212) | 2.16182590 |
| 81 | Abdominal distention (HP:0003270) | 2.15834031 |
| 82 | Abnormality of complement system (HP:0005339) | 2.14810729 |
| 83 | Recurrent abscess formation (HP:0002722) | 2.14258325 |
| 84 | Hypertensive crisis (HP:0100735) | 2.13388180 |
| 85 | IgM deficiency (HP:0002850) | 2.13055683 |
| 86 | Dyschromatopsia (HP:0007641) | 2.12178611 |
| 87 | Protuberant abdomen (HP:0001538) | 2.10580841 |
| 88 | Curly hair (HP:0002212) | 2.10195154 |
| 89 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.09540987 |
| 90 | Loss of speech (HP:0002371) | 2.09302253 |
| 91 | Hypergammaglobulinemia (HP:0010702) | 2.08672806 |
| 92 | Abnormal foot bone ossification (HP:0010675) | 2.07108382 |
| 93 | Insulin resistance (HP:0000855) | 2.07061942 |
| 94 | Autoimmune hemolytic anemia (HP:0001890) | 2.06011305 |
| 95 | Pancreatitis (HP:0001733) | 2.05904661 |
| 96 | Type I transferrin isoform profile (HP:0003642) | 2.05634224 |
| 97 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.04783923 |
| 98 | Acute hepatic failure (HP:0006554) | 2.04280684 |
| 99 | Reduced antithrombin III activity (HP:0001976) | 2.03985151 |
| 100 | Microvesicular hepatic steatosis (HP:0001414) | 2.02905140 |
| 101 | Abnormal platelet function (HP:0011869) | 2.02804613 |
| 102 | Impaired platelet aggregation (HP:0003540) | 2.02804613 |
| 103 | Lower limb hyperreflexia (HP:0002395) | 2.02511167 |
| 104 | Exocrine pancreatic insufficiency (HP:0001738) | 2.01713696 |
| 105 | Tetraparesis (HP:0002273) | 1.99774240 |
| 106 | Hematochezia (HP:0002573) | 1.97204921 |
| 107 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.96478063 |
| 108 | Myositis (HP:0100614) | 1.96340298 |
| 109 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.96166254 |
| 110 | Abnormality of nucleobase metabolism (HP:0010932) | 1.95240612 |
| 111 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.94418054 |
| 112 | Dicarboxylic aciduria (HP:0003215) | 1.94418054 |
| 113 | Osteomyelitis (HP:0002754) | 1.94096891 |
| 114 | Epistaxis (HP:0000421) | 1.93930755 |
| 115 | Recurrent otitis media (HP:0000403) | 1.93542558 |
| 116 | Abnormality of glycolipid metabolism (HP:0010969) | 1.93398567 |
| 117 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.93398567 |
| 118 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.93398567 |
| 119 | Abnormal tarsal ossification (HP:0008369) | 1.93138076 |
| 120 | Systemic lupus erythematosus (HP:0002725) | 1.92296403 |
| 121 | Gastrointestinal stroma tumor (HP:0100723) | 1.91801398 |
| 122 | Beaking of vertebral bodies (HP:0004568) | 1.91771582 |
| 123 | Vasculitis (HP:0002633) | 1.91162393 |
| 124 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.88235001 |
| 125 | Polygenic inheritance (HP:0010982) | 1.87987326 |
| 126 | Chronic otitis media (HP:0000389) | 1.87301309 |
| 127 | Elevated alkaline phosphatase (HP:0003155) | 1.86539239 |
| 128 | Glomerulonephritis (HP:0000099) | 1.86482112 |
| 129 | Male infertility (HP:0003251) | 1.86408772 |
| 130 | Prolonged bleeding time (HP:0003010) | 1.85934077 |
| 131 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.85572087 |
| 132 | Severe short stature (HP:0003510) | 1.85401305 |
| 133 | B lymphocytopenia (HP:0010976) | 1.84544854 |
| 134 | Abnormal protein glycosylation (HP:0012346) | 1.84449360 |
| 135 | Abnormal glycosylation (HP:0012345) | 1.84449360 |
| 136 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.84449360 |
| 137 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.84449360 |
| 138 | Increased cerebral lipofuscin (HP:0011813) | 1.84363233 |
| 139 | Fatigue (HP:0012378) | 1.84200351 |
| 140 | Prolonged neonatal jaundice (HP:0006579) | 1.83757840 |
| 141 | Verrucae (HP:0200043) | 1.82896527 |
| 142 | Papilloma (HP:0012740) | 1.82896527 |
| 143 | Thoracic kyphosis (HP:0002942) | 1.82876734 |
| 144 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.82221357 |
| 145 | Erythema (HP:0010783) | 1.81731262 |
| 146 | Hyperlipoproteinemia (HP:0010980) | 1.79774985 |
| 147 | Flat acetabular roof (HP:0003180) | 1.79607883 |
| 148 | Abnormal pancreas size (HP:0012094) | 1.79219312 |
| 149 | Hypolipoproteinemia (HP:0010981) | 1.78272748 |
| 150 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.76805252 |
| 151 | Meningitis (HP:0001287) | 1.76769083 |
| 152 | Periodontitis (HP:0000704) | 1.75090151 |
| 153 | Microretrognathia (HP:0000308) | 1.74382484 |
| 154 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.74043845 |
| 155 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.73628706 |
| 156 | Multiple enchondromatosis (HP:0005701) | 1.73618456 |
| 157 | Menorrhagia (HP:0000132) | 1.73492942 |
| 158 | Hepatocellular carcinoma (HP:0001402) | 1.73354252 |
| 159 | Epidermoid cyst (HP:0200040) | 1.73229323 |
| 160 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.72298792 |
| 161 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.71821012 |
| 162 | Abnormality of B cell number (HP:0010975) | 1.71534373 |
| 163 | Hyperammonemia (HP:0001987) | 1.71113115 |
| 164 | Gingival bleeding (HP:0000225) | 1.70928155 |
| 165 | Cervical subluxation (HP:0003308) | 1.70727345 |
| 166 | Upper motor neuron abnormality (HP:0002127) | 1.70521261 |
| 167 | Hemorrhage of the eye (HP:0011885) | 1.69550707 |
| 168 | Recurrent fungal infections (HP:0002841) | 1.69443161 |
| 169 | Reticulocytosis (HP:0001923) | 1.69335662 |
| 170 | Skin rash (HP:0000988) | 1.68933496 |
| 171 | Granulocytopenia (HP:0001913) | 1.68289106 |
| 172 | T lymphocytopenia (HP:0005403) | 1.67468205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.37962874 |
| 2 | TAOK3 | 3.24212661 |
| 3 | BCKDK | 2.96542285 |
| 4 | TRIB3 | 2.90547792 |
| 5 | FLT3 | 2.80831957 |
| 6 | FRK | 2.63681146 |
| 7 | INSRR | 2.42533540 |
| 8 | PASK | 2.18084152 |
| 9 | PKN2 | 2.17312528 |
| 10 | SCYL2 | 2.16361442 |
| 11 | MAP4K1 | 2.13835596 |
| 12 | IRAK3 | 2.09218042 |
| 13 | BMPR2 | 2.08895796 |
| 14 | SIK1 | 1.95934917 |
| 15 | PRPF4B | 1.85692373 |
| 16 | EIF2AK3 | 1.82877334 |
| 17 | MAP3K10 | 1.81878108 |
| 18 | TYK2 | 1.76367873 |
| 19 | RIPK4 | 1.75097982 |
| 20 | NME2 | 1.74758338 |
| 21 | SRPK1 | 1.73228001 |
| 22 | AKT3 | 1.70105139 |
| 23 | PTK6 | 1.64721829 |
| 24 | TBK1 | 1.63882121 |
| 25 | JAK3 | 1.51131576 |
| 26 | LRRK2 | 1.46035272 |
| 27 | NEK9 | 1.42894856 |
| 28 | IRAK4 | 1.41762554 |
| 29 | SMG1 | 1.41569283 |
| 30 | FGFR4 | 1.41553474 |
| 31 | ZAP70 | 1.41190398 |
| 32 | EEF2K | 1.38403621 |
| 33 | BTK | 1.38001843 |
| 34 | MST4 | 1.36782112 |
| 35 | CSF1R | 1.34606634 |
| 36 | BLK | 1.34404959 |
| 37 | SIK3 | 1.30926559 |
| 38 | HIPK2 | 1.29459170 |
| 39 | EPHA3 | 1.29456826 |
| 40 | MAP3K13 | 1.28396100 |
| 41 | BCR | 1.26951275 |
| 42 | MAPK15 | 1.26570618 |
| 43 | CDK19 | 1.25260614 |
| 44 | RPS6KA4 | 1.25144894 |
| 45 | JAK1 | 1.20513730 |
| 46 | PIK3CG | 1.18409953 |
| 47 | ERBB3 | 1.17947843 |
| 48 | STK10 | 1.17638663 |
| 49 | DYRK1B | 1.15773826 |
| 50 | CSK | 1.14544078 |
| 51 | MAP3K3 | 1.14499593 |
| 52 | MAP2K7 | 1.12358685 |
| 53 | LATS1 | 1.12172394 |
| 54 | ARAF | 1.11376464 |
| 55 | TEC | 1.10007297 |
| 56 | TGFBR2 | 1.05095282 |
| 57 | MAP3K14 | 1.03070032 |
| 58 | MAPKAPK3 | 0.98843377 |
| 59 | MAP3K2 | 0.98026661 |
| 60 | MAP3K6 | 0.97679685 |
| 61 | MAP2K3 | 0.96919464 |
| 62 | EPHB1 | 0.95179710 |
| 63 | TRIM28 | 0.95157778 |
| 64 | TESK1 | 0.94005949 |
| 65 | TESK2 | 0.92667781 |
| 66 | KIT | 0.91956236 |
| 67 | GRK6 | 0.90868095 |
| 68 | STK38L | 0.89886811 |
| 69 | KSR2 | 0.89644039 |
| 70 | BRSK2 | 0.89571816 |
| 71 | JAK2 | 0.89564139 |
| 72 | MAP2K2 | 0.83449803 |
| 73 | ITK | 0.83349248 |
| 74 | TAOK2 | 0.82264068 |
| 75 | CSNK1G3 | 0.80723179 |
| 76 | NUAK1 | 0.78837488 |
| 77 | MAP3K12 | 0.78333749 |
| 78 | MAP3K4 | 0.77717002 |
| 79 | SYK | 0.77555988 |
| 80 | RIPK1 | 0.76719903 |
| 81 | PDGFRA | 0.75923497 |
| 82 | BRD4 | 0.75598095 |
| 83 | FGFR3 | 0.75298311 |
| 84 | IRAK1 | 0.74807685 |
| 85 | IKBKE | 0.74640301 |
| 86 | BRAF | 0.73724012 |
| 87 | CDK8 | 0.73466414 |
| 88 | MAP3K5 | 0.71423370 |
| 89 | NLK | 0.70966802 |
| 90 | STK24 | 0.70290521 |
| 91 | LYN | 0.69495201 |
| 92 | EIF2AK1 | 0.69149716 |
| 93 | KDR | 0.69098948 |
| 94 | PIM2 | 0.68995495 |
| 95 | IKBKB | 0.68418966 |
| 96 | YES1 | 0.66813953 |
| 97 | MET | 0.65008659 |
| 98 | RAF1 | 0.63706987 |
| 99 | CSNK1A1L | 0.63696797 |
| 100 | CDK6 | 0.63379942 |
| 101 | MST1R | 0.62631534 |
| 102 | PIM1 | 0.62239716 |
| 103 | CHUK | 0.59675228 |
| 104 | MAPK11 | 0.59193636 |
| 105 | DYRK3 | 0.57987976 |
| 106 | CAMK1D | 0.57196374 |
| 107 | MAP3K8 | 0.54042656 |
| 108 | CDK9 | 0.52822779 |
| 109 | MAP3K1 | 0.52769202 |
| 110 | DAPK1 | 0.51285636 |
| 111 | LCK | 0.50788545 |
| 112 | STK3 | 0.50459615 |
| 113 | RPS6KB2 | 0.50236126 |
| 114 | TSSK6 | 0.49145715 |
| 115 | PTK2 | 0.49063561 |
| 116 | CDK7 | 0.47442242 |
| 117 | MARK3 | 0.43017909 |
| 118 | PAK2 | 0.40426782 |
| 119 | HCK | 0.39276063 |
| 120 | DAPK3 | 0.38900432 |
| 121 | CSNK1G2 | 0.38746040 |
| 122 | PBK | 0.38306395 |
| 123 | EIF2AK2 | 0.37531311 |
| 124 | PDGFRB | 0.37118644 |
| 125 | EGFR | 0.36197327 |
| 126 | GSK3A | 0.35650036 |
| 127 | MTOR | 0.32765902 |
| 128 | CAMKK2 | 0.32462685 |
| 129 | ABL1 | 0.32410274 |
| 130 | IGF1R | 0.30704915 |
| 131 | MAP3K11 | 0.30436739 |
| 132 | EPHA2 | 0.28833028 |
| 133 | PAK4 | 0.28607770 |
| 134 | CDK4 | 0.26335412 |
| 135 | STK4 | 0.25772543 |
| 136 | MATK | 0.25271671 |
| 137 | WNK4 | 0.24535324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.69922385 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.14112110 |
| 3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.18021928 |
| 4 | Asthma_Homo sapiens_hsa05310 | 2.54656886 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.47424139 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.27196162 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.26668900 |
| 8 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.18942116 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.15056160 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.13458017 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.09370531 |
| 12 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.02825221 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.97425145 |
| 14 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.88862825 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.85428357 |
| 16 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.72846922 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.71318780 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.69438492 |
| 19 | Proteasome_Homo sapiens_hsa03050 | 1.65647007 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.65038290 |
| 21 | Shigellosis_Homo sapiens_hsa05131 | 1.64039780 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.63769676 |
| 23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.58493448 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.58146985 |
| 25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.56277685 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.45089898 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.41991114 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.41747629 |
| 29 | Lysosome_Homo sapiens_hsa04142 | 1.37672543 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.35192356 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.31943824 |
| 32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.31529568 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.29111948 |
| 34 | Spliceosome_Homo sapiens_hsa03040 | 1.27827359 |
| 35 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.24382596 |
| 36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.19624988 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.16774980 |
| 38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.16281035 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14894719 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.13513377 |
| 41 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.12815142 |
| 42 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.10647785 |
| 43 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.10371064 |
| 44 | Base excision repair_Homo sapiens_hsa03410 | 1.09798418 |
| 45 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.09392201 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08880878 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.08567984 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 1.08416009 |
| 49 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.07700168 |
| 50 | DNA replication_Homo sapiens_hsa03030 | 1.05212894 |
| 51 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.02008809 |
| 52 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.00781258 |
| 53 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.00270361 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99786744 |
| 55 | Leishmaniasis_Homo sapiens_hsa05140 | 0.99230772 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.98990337 |
| 57 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.96181994 |
| 58 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.95894298 |
| 59 | Ribosome_Homo sapiens_hsa03010 | 0.93024131 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.92874169 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 0.92450835 |
| 62 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.91497542 |
| 63 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.90408527 |
| 64 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.90138479 |
| 65 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.89872712 |
| 66 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.89783475 |
| 67 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.89018671 |
| 68 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.88354392 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.86634746 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 0.85709701 |
| 71 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.85070921 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.83844112 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81745011 |
| 74 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.80330371 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.79481520 |
| 76 | Thyroid cancer_Homo sapiens_hsa05216 | 0.77224007 |
| 77 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.76951372 |
| 78 | Mismatch repair_Homo sapiens_hsa03430 | 0.75931116 |
| 79 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.75267930 |
| 80 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.75136092 |
| 81 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.74570173 |
| 82 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.74170243 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71923606 |
| 84 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.69137387 |
| 85 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.68871519 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68774772 |
| 87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.67345683 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66536346 |
| 89 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66143166 |
| 90 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.64945094 |
| 91 | Lysine degradation_Homo sapiens_hsa00310 | 0.63835700 |
| 92 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.63614937 |
| 93 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62650739 |
| 94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61875791 |
| 95 | RNA transport_Homo sapiens_hsa03013 | 0.61253924 |
| 96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60891812 |
| 97 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.60684471 |
| 98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.60643175 |
| 99 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59995481 |
| 100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.59341525 |
| 101 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58368427 |
| 102 | Pertussis_Homo sapiens_hsa05133 | 0.58145381 |
| 103 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.56158846 |
| 104 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55707640 |
| 105 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.55084201 |
| 106 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.54505367 |
| 107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53760151 |
| 108 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.53759018 |
| 109 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53387886 |
| 110 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53381799 |
| 111 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.52578662 |
| 112 | Measles_Homo sapiens_hsa05162 | 0.50786834 |
| 113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50783891 |
| 114 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49204604 |
| 115 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49014125 |
| 116 | Influenza A_Homo sapiens_hsa05164 | 0.48970424 |
| 117 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48758857 |
| 118 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48346313 |
| 119 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.48174146 |
| 120 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.47074739 |
| 121 | Tuberculosis_Homo sapiens_hsa05152 | 0.46695497 |
| 122 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.46139430 |
| 123 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.46128851 |
| 124 | Hepatitis C_Homo sapiens_hsa05160 | 0.45731414 |
| 125 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.45538670 |
| 126 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.45195466 |
| 127 | Apoptosis_Homo sapiens_hsa04210 | 0.45117156 |
| 128 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44773921 |
| 129 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44704714 |
| 130 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.43750576 |
| 131 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42994130 |
| 132 | Bladder cancer_Homo sapiens_hsa05219 | 0.42616832 |
| 133 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.42249539 |
| 134 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.42235017 |
| 135 | Hepatitis B_Homo sapiens_hsa05161 | 0.41829514 |
| 136 | Retinol metabolism_Homo sapiens_hsa00830 | 0.41780143 |
| 137 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.41690469 |
| 138 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41344761 |
| 139 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41251190 |
| 140 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41244990 |
| 141 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.39579660 |
| 142 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.38996169 |
| 143 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.38148633 |
| 144 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36761042 |

